| 000 | 01746 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513140331.0 | ||
| 264 | 0 | _c19980409 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDawson, N | |
| 245 | 0 | 0 |
_aPhase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 1998 |
||
| 300 |
_a37-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAminoglutethimide _xadministration & dosage |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSuramin _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aFigg, W D | |
| 700 | 1 | _aBrawley, O W | |
| 700 | 1 | _aBergan, R | |
| 700 | 1 | _aCooper, M R | |
| 700 | 1 | _aSenderowicz, A | |
| 700 | 1 | _aHeadlee, D | |
| 700 | 1 | _aSteinberg, S M | |
| 700 | 1 | _aSutherland, M | |
| 700 | 1 | _aPatronas, N | |
| 700 | 1 | _aSausville, E | |
| 700 | 1 | _aLinehan, W M | |
| 700 | 1 | _aReed, E | |
| 700 | 1 | _aSartor, O | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 4 _gno. 1 _gp. 37-44 |
|
| 999 |
_c9484695 _d9484695 |
||